The startup develops bioprinting technologies that enable researchers to create realistic human-like tissues using 3D bioprinting methods. This technology provides a platform for studying human cell behavior in both healthy and disease states, enhancing the understanding of tissue development and pathology.
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Creating artificial human tissues for research and medical applications is complex, often requiring specialized materials and techniques. Traditional methods can be expensive and time-consuming, hindering progress in drug testing, disease modeling, and regenerative medicine.
Solution
Smart Tissues develops innovative biomaterials and bioprinting technologies that enable researchers to create realistic, functional human tissues. Their platform facilitates the 3D printing of living tissues, providing a means to study cell behavior in both healthy and diseased states. By offering customized biotink formulations, Smart Tissues empowers researchers to focus on their core research without being limited by material constraints.
Target Audience
The primary customers are researchers in the fields of pharmacology, cosmetics, and medicine, as well as organizations involved in drug development, basic research, and tissue engineering.
Features
- Development of customized biotink formulations tailored to specific tissue types and research applications.
- Bioprinting technology enabling the creation of 3D human tissue models.
- Materials suitable for drug testing, disease modeling, and regenerative medicine research.